Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Clinical Microbiology & Infectious Diseases
Literatur
1.
Seaton RA, Johal S, Coia JE et al (2014) Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals. Eur J Clin Microbiol Infect Dis 33:305–311PubMedCrossRef
2.
Gould FK, Brindle R, Chadwick PR et al (2009) Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 63:849–861PubMedCrossRef
3.
Dryden M, Andrasevic AT, Bassetti M et al (2010) A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 16(Suppl 1):3–30PubMedCrossRef
4.
Seaton RA, Sharp E, Bezlyak V et al (2011) Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents 38:243–248PubMedCrossRef
5.
Chapman ALN, Seaton RA, Cooper MA et al (2012) Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 67:1053–1062PubMedCrossRef
6.
Cunha BA (2001) Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia. Am J Med 111:412–413PubMedCrossRef
7.
Cunha BA (2004) Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come. Eur J Clin Microbiol Infect Dis 23:78–81PubMedCrossRef
8.
Cunha BA (2005) Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 11:33–42PubMedCrossRef
9.
Cunha BA (2014) Cephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited. J Chemother 26:65–66PubMedCrossRef
10.
Cunha BA (1998) Factors in antibiotic selection for hospital formularies (part I). Hosp Formul 33:558–572
11.
Cunha BA (2008) Oral and i.v.-to-p.o. switch antibiotic therapy of hospitalized patients with serious infections. Scand J Infect Dis 40:1004–1006PubMedCrossRef
12.
Cunha BA (2006) Oral antibiotic therapy of serious systemic infections. Med Clin North Am 90:1197–1222PubMedCrossRef
13.
Rubinstein E, Keynan Y (2013) Short-course therapy for severe infections. Int J Antimicrob Agents 42:S22–S24PubMedCrossRef
14.
Lidji M, Rubinstein E, Samra H (1978) Bacterial endocarditis on a prosthetic valve. Oral treatment with amoxicillin. Chest 74:224–225PubMedCrossRef
15.
16.
Cunha BA (ed) (2013) Antibiotic essentials, 12th edn. Jones and Bartlett, Sudbury, pp 8–16, 132–135, 595–597, 647–648, 680–682
17.
Kucers A, Crowe SM, Grayson ML et al (eds) (1997) Kucers’ the use of antibiotics, 4th edn. Butterworth-Heinemann, Oxford, pp 719–763
18.
McKinnon PS, Sorensen SV, Liu LZ, Itani KM (2006) Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. Ann Pharmacother 40:1017–1023PubMedCrossRef
19.
Schwartz BS, Graber CJ, Diep BA et al (2009) Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clin Infect Dis 48:1483–1484PubMedCrossRef
20.
Cunha BA (1997) Problems arising in antimicrobial therapy due to false susceptibility testing. J Chemother 9:25–35PubMed
21.
Cunha BA (2010) Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness. Int J Antimicrob Agents 35:517–518PubMedCrossRef
22.
Cunha BA (2013) Minocycline, often forgotten but preferred to trimethoprim–sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Int J Antimicrob Agents 42:497–499PubMedCrossRef
23.
Gray A, Dryden M, Charos A (2012) Antibiotic management and early discharge from hospital: an economic analysis. J Antimicrob Chemother 67:2297–2302PubMedCrossRef
24.
Dryden M, Saeed K, Townsend R et al (2012) Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemother 67:2289–2296PubMedCrossRef
25.
Cunha BA (2014) Minocycline is a reliable and effective oral option to treat meticillin-resistant Staphylococcus aureus skin and soft-tissue infections, including doxycycline treatment failures. Int J Antimicrob Agents 43:386–387PubMedCrossRef
Metadaten
Titel
Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)
verfasst von
B. A. Cunha
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2014
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2113-z

Weitere Artikel der Ausgabe 10/2014

European Journal of Clinical Microbiology & Infectious Diseases 10/2014 Zur Ausgabe

Review

Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review

Article

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia

Article

Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer

Article

Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole

Article

Social determinants associated with Giardia duodenalis infection in southern Côte d’Ivoire

Article

Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise